CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,891,000 | +335.7% | 1,428,200 | +2741.3% | 1.65% | +2598.4% |
| Q4 2017 | $3,418,000 | -32.3% | 50,266 | -18.0% | 0.06% | -19.7% |
| Q3 2017 | $5,050,000 | +399.5% | 61,300 | +467.6% | 0.08% | +406.7% |
| Q2 2017 | $1,011,000 | +33.9% | 10,800 | -9.0% | 0.02% | +36.4% |
| Q1 2017 | $755,000 | +70.0% | 11,869 | +18.7% | 0.01% | +37.5% |
| Q4 2016 | $444,000 | +2.5% | 10,000 | -16.8% | 0.01% | +14.3% |
| Q3 2016 | $433,000 | +104.2% | 12,015 | +8.7% | 0.01% | +75.0% |
| Q1 2016 | $212,000 | -52.7% | 11,057 | +116.8% | 0.00% | -33.3% |
| Q2 2015 | $448,000 | -76.8% | 5,100 | -88.0% | 0.01% | -76.0% |
| Q3 2014 | $1,928,000 | +10.6% | 42,500 | +1.0% | 0.02% | +19.0% |
| Q2 2014 | $1,743,000 | – | 42,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |